Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in women with stage IB-IIB cervical cancer: Do we need to change the therapeutic approach? A cohort study

Background: Chemoradiotherapy is recommended as the standard treatment for advanced cervical cancer, and neoadjuvant chemotherapy (NACT) can be beneficial for patients on long radiotherapy waiting lists. This study aimed to evaluate the need for chemoradiotherapy after NACT and radical hysterectomy...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Somayeh Nikfar, Azam Sadat Mousavi, Setareh Akhavan, Shahrzad Sheikhhasani, Amir Almasi-Hashiani, Ramin Parvizrad, Narges Zamani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-06-01
Edice:	Surgery in Practice and Science
Témata:	Chemo-radiotherapy Neoadjuvant chemotherapy Radical hysterectomy Cervical cancer Progression-free survival
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666262025000130
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!